More charges against ex-pharmaceutical executive Shkreli
NEW YORK- Federal prosecutors in New York have filed additional criminal charges against a pharmaceutical executive who separately was heavily criticized for raising the price of a lifesaving malaria medication.
A new indictment filed Friday in Brooklyn says Martin Shkreli and his former attorney Evan Greebel schemed to defraud potential investors of his former drug company Retrophin Inc., based in San Diego. They say the two allocated company stock to seven employees to conceal Shkreli's ownership of it.
Shkreli previously pleaded not guilty to charges he lost investors' money through bad trades and looted the pharmaceutical company to pay them back.
Shkreli already was reviled because another drug company he owned raised the price of Daraprim by 5,000 percent.
Shkreli's attorney says the allegations won't change the "flawed theory" of the case. Greebel's lawyer has no comment.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Odd monolith sculpture discovered in Utah desert
State leaders choose contractors for massive I-10 widening project
Vehicle fire causes slowdown on I-10 W at Lobdell
EBR schools feel unable to meet educational needs of certain students due...
Planned Parenthood in Louisiana may lose funding
Catholic freshman Daniel Beale has been thrown into super stardom thanks to...
Can Jameis Winston lead this Saints offense?; Fantasy Focus Week 11 with...
Fans' Choice Award Winner 2020: Week 7 - Baylor Langlois
Clay Polk is Central football's master of mystery
Late defensive stands and timely passing give Catholic 27-21 win over Acadiana